Larson Financial Group’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $85K | Buy |
473
+150
| +46% | +$26.9K | ﹤0.01% | 899 |
|
|
2025
Q1 | $54.7K | Buy |
323
+163
| +102% | +$27.6K | ﹤0.01% | 986 |
|
|
2024
Q4 | $24.1K | Sell |
160
-70
| -30% | -$10.6K | ﹤0.01% | 1143 |
|
|
2024
Q3 | $35.8K | Buy |
230
+1
| +0.4% | +$156 | ﹤0.01% | 1003 |
|
|
2024
Q2 | $31.4K | Buy |
229
+100
| +78% | +$13.7K | ﹤0.01% | 924 |
|
|
2024
Q1 | $17.2K | Sell |
129
-40
| -24% | -$5.33K | ﹤0.01% | 918 |
|
|
2023
Q4 | $23.3K | Hold |
169
| – | – | ﹤0.01% | 815 |
|
|
2023
Q3 | $20.6K | Hold |
169
| – | – | ﹤0.01% | 808 |
|
|
2023
Q2 | $23.7K | Hold |
169
| – | – | ﹤0.01% | 695 |
|
|
2023
Q1 | $23.8K | Buy |
169
+1
| +0.6% | +$141 | ﹤0.01% | 698 |
|
|
2022
Q4 | $26.3K | Hold |
168
| – | – | ﹤0.01% | 635 |
|
|
2022
Q3 | $21K | Sell |
168
-179
| -52% | -$22.4K | ﹤0.01% | 623 |
|
|
2022
Q2 | $46K | Buy |
347
+318
| +1,097% | +$42.2K | 0.01% | 386 |
|
|
2022
Q1 | $4K | Hold |
29
| – | – | ﹤0.01% | 814 |
|
|
2021
Q4 | $5K | Hold |
29
| – | – | ﹤0.01% | 802 |
|
|
2021
Q3 | $4K | Hold |
29
| – | – | ﹤0.01% | 715 |
|
|
2021
Q2 | $4K | Buy |
29
+1
| +4% | +$138 | ﹤0.01% | 648 |
|
|
2021
Q1 | $4K | Hold |
28
| – | – | ﹤0.01% | 645 |
|
|
2020
Q4 | $3K | Hold |
28
| – | – | ﹤0.01% | 597 |
|
|
2020
Q3 | $3K | Hold |
28
| – | – | ﹤0.01% | 561 |
|
|
2020
Q2 | $3K | Buy |
+28
| New | +$3K | ﹤0.01% | 522 |
|